Multiple Sclerosis and Respiratory Health: Indirect Effects and Management

MS primarily affects the CNS, but respiratory complications arise from:

  • Respiratory muscle weakness: Diaphragm/intercostal paresis → hypoventilation, especially supine.
  • Reduced cough effectiveness: Impaired secretion clearance → atelectasis, pneumonia.
  • Dysphagia: Aspiration risk.
  • Fatigue and inactivity: Deconditioning.
  • Autonomic dysfunction: Altered breathing control, sleep‑disordered breathing.
  • Medication effects: Some DMTs (e.g., fingolimod) may cause pulmonary function decline.

Monitoring and Intervention

  • Pulmonary function tests (spirometry, MIP/MEP) periodically.
  • Respiratory therapy: incentive spirometry, assisted cough, NIV if needed.
  • Vaccinations (pneumococcal, influenza, COVID).
  • Swallowing evaluation for dysphagia.
  • Exercise within limits to maintain respiratory muscle strength.

Multiple Sclerosis - Related Articles